Prognosis for patients with thin cutaneous melanoma
暂无分享,去创建一个
W. McCarthy | Xue Qin Yu | John F Thompson | William H McCarthy | J Gregory McKinnon | J. Mckinnon | J. Thompson | J. F. Thompson | X. Yu
[1] S. George,et al. The long‐term clinical course of patients with cutaneous melanoma , 2002, Cancer.
[2] J. Kirkwood,et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D L Morton,et al. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by clark level and breslow thickness , 1993, Cancer.
[4] Yuting Zhang,et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma , 2003, Cancer.
[5] K. Jöckel,et al. Skin melanoma in Saarland: incidence, survival and mortality 1970–1996 , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[6] Martin F. Mihm,et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Berwick,et al. Predicting five‐year outcome for patients with cutaneous melanoma in a population‐based study , 1996, Cancer.
[8] N. Cascinelli,et al. Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics , 1981, Cancer.
[9] R. MacKie,et al. Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. , 1995, British Journal of Cancer.
[10] U. Ringborg,et al. Prognostic factors in thin cutaneous malignant melanoma , 1994, Cancer.
[11] P. Carli,et al. Skin melanoma in Italy: a population-based study on survival and prognostic factors. , 1998, European journal of cancer.
[12] H. Olsson,et al. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review , 2001, Melanoma research.
[13] C. Garbe,et al. Author reply to previously published correspondence , 2002, Cancer.
[14] F. Meyskens,et al. Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease , 1988, Cancer.
[15] L. Karnell,et al. The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.
[16] C. Garbe,et al. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification , 1995, Cancer.
[17] D. Reintgen,et al. Lethal “Thin” Malignant Melanoma: Identifying Patients at Risk , 1988, Annals of surgery.
[18] R. MacKie,et al. The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. , 1991, British Journal of Cancer.
[19] D L Morton,et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.
[20] A. Sober,et al. Ultra‐late recurrence (15 years or longer) of cutaneous melanoma , 1997, Cancer.
[21] C. Karakousis,et al. Tumor thickness and prognosis in clinical stage I malignant melanoma , 1989, Cancer.
[22] A. Halpern,et al. A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma , 1996, Annals of Internal Medicine.
[23] J. Thompson,et al. Cutaneous melanomas that defy conventional prognostic indicators. , 1996, Seminars in oncology.
[24] N Cascinelli,et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. McCarthy,et al. Thin malignant melanomas and recurrence potential. , 1987, Archives of surgery.
[26] J Sunil Rao,et al. A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging. , 2002, Surgery.
[27] Raymond L. Barnhill,et al. Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas , 2001, Annals of Surgical Oncology.
[28] C. Holman,et al. Survival among patients with clinical stage i cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981 , 1991, Cancer.